Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 3/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.44 |
| ▸ | MVD | P53602 | 2/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10796477 | 1.00 | BTN3A1 (0.47) | BTN3A1LPAR3LPAR2LPAR1MVD | |
| SCHEMBL4971483 | 1.00 | BTN3A1 (0.47) | BTN3A1LPAR3LPAR2LPAR1MVD | |
| SCHEMBL27730052 | 0.97 | BTN3A1 (0.45) | BTN3A1LPAR3LPAR2LPAR1MVD | |
| SCHEMBL1123897 | 0.93 | LPAR3 (0.42) | BTN3A1LPAR3LPAR2LPAR1SMPD1 | |
| SCHEMBL125995 | 0.89 | LPAR3 (0.45) | LPAR3LPAR2LPAR1SMPD1 | |
| SCHEMBL230886 | 0.89 | LPAR3 (0.45) | LPAR3LPAR2LPAR1SMPD1 | |
| SCHEMBL3690198 | 0.89 | LPAR3 (0.45) | LPAR3LPAR2LPAR1SMPD1 | |
| SCHEMBL22471656 | 0.89 | LPAR3 (0.45) | LPAR3LPAR2LPAR1SMPD1 | |
| SCHEMBL28514460 | 0.89 | LPAR3 (0.45) | LPAR3LPAR2LPAR1SMPD1 | |
| SCHEMBL641417 | 0.89 | LPAR3 (0.45) | LPAR3LPAR2LPAR1SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1933848-A2 | PHOSPHOANTIGEN SALTS OF ORGANIC BASES AND METHODS FOR THEIR CRYSTALLIZATION | Innate Pharma (FR) | 2008-06-25 | — | — | EP | disclosed |
| WO-2007039635-A2 | PHOSPHOANTIGEN SALTS OF ORGANIC BASES AND METHODS FOR THEIR CRYSTALLIZATION | INNATE PHARMA (FR) | 2007-04-12 | — | — | WO | disclosed |